CRBU
Price
$1.87
Change
+$0.02 (+1.08%)
Updated
Sep 5 closing price
Capitalization
174.14M
66 days until earnings call
MGNX
Price
$2.00
Change
+$0.06 (+3.09%)
Updated
Sep 5 closing price
Capitalization
126.41M
66 days until earnings call
Interact to see
Advertisement

CRBU vs MGNX

Header iconCRBU vs MGNX Comparison
Open Charts CRBU vs MGNXBanner chart's image
Caribou Biosciences
Price$1.87
Change+$0.02 (+1.08%)
Volume$482.11K
Capitalization174.14M
MacroGenics
Price$2.00
Change+$0.06 (+3.09%)
Volume$2.8M
Capitalization126.41M
CRBU vs MGNX Comparison Chart in %
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. MGNX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and MGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRBU: $1.87 vs. MGNX: $2.00)
Brand notoriety: CRBU and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 34% vs. MGNX: 358%
Market capitalization -- CRBU: $174.14M vs. MGNX: $126.41M
CRBU [@Biotechnology] is valued at $174.14M. MGNX’s [@Biotechnology] market capitalization is $126.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while MGNX’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 2 bearish.
  • MGNX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than MGNX.

Price Growth

CRBU (@Biotechnology) experienced а 0.00% price change this week, while MGNX (@Biotechnology) price change was +12.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 11, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($174M) has a higher market cap than MGNX($126M). CRBU YTD gains are higher at: 17.610 vs. MGNX (-38.462). MGNX has higher annual earnings (EBITDA): -26.91M vs. CRBU (-150.76M). CRBU (184M) and MGNX (176M) have equal amount of cash in the bank . CRBU has less debt than MGNX: CRBU (25.9M) vs MGNX (37.2M). MGNX has higher revenues than CRBU: MGNX (164M) vs CRBU (9.12M).
CRBUMGNXCRBU / MGNX
Capitalization174M126M138%
EBITDA-150.76M-26.91M560%
Gain YTD17.610-38.462-46%
P/E RatioN/AN/A-
Revenue9.12M164M6%
Total Cash184M176M105%
Total Debt25.9M37.2M70%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUMGNX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPOAY21.440.57
+2.73%
Epiroc Aktiebolag
ILLMF1.10N/A
N/A
illumin Holdings Inc.
ADCNF0.65N/A
N/A
ADICON HLDGS LTD.
CDTAF0.03N/A
-0.30%
INFINITII AI INC.
CZMWY48.52-0.23
-0.47%
Carl Zeiss Meditec AG

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+1.08%
CRSP - CRBU
59%
Loosely correlated
+4.02%
BEAM - CRBU
54%
Loosely correlated
+12.62%
FATE - CRBU
53%
Loosely correlated
+3.81%
MGNX - CRBU
53%
Loosely correlated
+3.09%
RXRX - CRBU
52%
Loosely correlated
+1.99%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+3.09%
XNCR - MGNX
54%
Loosely correlated
+2.15%
CRBU - MGNX
53%
Loosely correlated
+1.08%
RGNX - MGNX
53%
Loosely correlated
+3.08%
BEAM - MGNX
51%
Loosely correlated
+12.62%
FATE - MGNX
50%
Loosely correlated
+3.81%
More